Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen
Author:
Publisher
Informa UK Limited
Subject
Gastroenterology,Hepatology
Link
http://www.tandfonline.com/doi/pdf/10.1586/egh.12.32
Reference16 articles.
1. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
2. Helicobacter pyloriInfection
3. Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor-based triple therapies fail
4. Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures
5. Helicobacter pylori"Rescue" Therapy After Failure of Two Eradication Treatments
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen;Helicobacter;2022-05-29
2. Rescue Therapies for H. pylori Infection in Italy;Antibiotics;2021-05-03
3. Efficacy and safety of a new rifabutin‐based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single‐arm study;Helicobacter;2020-06-29
4. Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics;Antimicrobial Resistance & Infection Control;2019-02-15
5. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: A pilot study;United European Gastroenterology Journal;2015-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3